background image

Paid Clinical Trials Austin

Discover 658 paid clinical trials in Austin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Investigational CMV Vaccine Study for Volunteers Ages 9–15

PHASE1
PHASE2

Sponsor:

Moderna

Location:

Austin, San Antonio, Victoria, Tomballshow 42 more

Code:

NCT05575492

Conditions

Cytomegalovirus

Eligibility Criteria

Sex: All

Age: 9 - 15

Healthy Volunteers: Accepted

Interventions

mRNA-1647

Placebo

Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)

Recruiting
PHASE3

Sponsor:

VistaGen Therapeutics, Inc.

Location:

Austin, Houston, Little Rock, Albuquerqueshow 8 more

Code:

NCT06615557

Conditions

Social Anxiety Disorder (SAD)

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Fasedienol Nasal Spray

Placebo Nasal Spray

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

Recruiting
PHASE1
PHASE2

Sponsor:

OncoResponse, Inc.

Location:

Austin, San Antonio, Irving, Fairfax

Code:

NCT06090266

Conditions

Cancer

Tumor, Solid

Malignant Neoplasm

Metastatic Cancer

Advanced Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

OR502

Cemiplimab

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Austin, Georgetown, Kerrville, Wacoshow 195 more

Code:

NCT06283966

Conditions

COPD (Chronic Obstructive Pulmonary Disease)

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

BGF MDI 320/14.4/9.6 μg

GFF MDI 14.4/9.6 μg

Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder

Recruiting
PHASE3

Sponsor:

Neumora Therapeutics, Inc.

Location:

Austin, Houston, Dallas, Wichita Fallsshow 55 more

Code:

NCT06029426

Conditions

Major Depressive Disorder

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

NMRA-335140

Placebo

A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Austin, San Antonio, Houston, Humbleshow 121 more

Code:

NCT06268873

Conditions

Chronic Kidney Disease and Hypertension

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Baxdrostat/dapagliflozin

Dapagliflozin in combination with placebo

A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis

Recruiting
PHASE3

Sponsor:

Priovant Therapeutics, Inc.

Location:

Austin, Round Rock, Katy, Bellaireshow 33 more

Code:

NCT06431373

Conditions

Uveitis, Posterior

Uveitis, Intermediate

Uveitis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Brepocitinib PO QD

Placebo PO QD

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Recruiting
PHASE2

Sponsor:

Allogene Therapeutics

Location:

Austin, San Antonio, Houston, Dallasshow 22 more

Code:

NCT06500273

Conditions

Large B-cell Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

cemacabtagene ansegedleucel

ALLO-647

Fludarabine

Cyclophosphamide

Foresight CLARITY™ IUO MRD test, powered by PhasED-Seq™

Epidemiological Study to Monitor Study Participants With Resected Stage II (High Risk) or Stage III Colorectal Cancer for Circulating Tumor DNA Before, During and After Their Treatment With Adjuvant Chemotherapy

Recruiting

Sponsor:

BioNTech SE

Location:

Austin, San Antonio, Dallas, Tylershow 13 more

Code:

NCT04813627

Conditions

Colorectal Cancer Stage II

Colorectal Cancer Stage III

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Regular blood sample collection for ctDNA assessment

A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies

Recruiting
PHASE1

Sponsor:

MacroGenics

Location:

Austin, Saint Louis, Denver, Grand Rapidsshow 3 more

Code:

NCT05362773

Conditions

Leukemia, Acute Myeloid

Myelodysplastic Syndromes

Classical Hodgkin Lymphoma

Leukemia, B-cell

Leukemia, Hairy Cell

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MGD024

A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease

Recruiting
PHASE3

Sponsor:

Pfizer

Location:

Austin, Cedar Park, Fort Sam Houston, Victoriashow 93 more

Code:

NCT04173273

Conditions

Crohn's Disease

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Etrasimod

Placebo

With a dynamic healthcare network and prominent research institutions, Austin is a significant hub for clinical trials. Key organizations like the Dell Medical School at the University of Texas at Austin, the Texas Diabetes Institute, and the Austin Cancer Center are leading advancements in medical research. These institutions are at the forefront of clinical studies, driving innovation across various fields and contributing to groundbreaking treatments and healthcare solutions.

Why choose Austin for clinical trials?

Common conditions studied in Austin

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Austin